PRİMER FİBROMYALJİ SENDROMLU KADIN HASTALARDA YAŞAM KALİTESİ DÜZEYİ VE İLİŞKİLİ FAKTÖRLER

Öz

Primer fibromiyalji tanılı kadın hastalarda uyku bozukluğu ve depresyon sıklığının ve hastalıkla ilişkili değişkenlerle yaşam kalitesi düzeyi arasındaki ilişkinin araştırılması. Çalışmaya 49 kadın hasta ve 27 sağlıklı kadından oluşan kontrol grubu katıldı. Hastaların ağrı şiddeti, depresyon varlığı ve şiddeti, uykusuzluk şiddeti ve yorgunluk şiddeti sırasıyla vizüel analog skala, Beck Depresyon Ölçeği, Pittsburg Uyku Kalitesi İndeksi, MFSI-SF çok boyutlu yorgunluk semptom envanteri-kısa form, Multidimensional Fatigue Symptom Inventory-Short Form ile değerlendirildi. Yaşam kalitesi düzeyi kısa form-36 KF-36 kullanılarak değerlendirildi. Hastalarımızın %91.8’inde uyku bozukluğu; %28.6’sında hafif, %10.2’sinde orta, %28’inde şiddetli ve %26.5’inde ağır depresyon ile %98’inde yorgunluk saptandı. Fibromiyaljili hastalarda KF-36’nın tüm alt grup ve mental komponent skor MKS ilefiziksel komponent skor FKS özet skorları daha düşüktü. Yorgunluk ile KF-36’nın FKS ve MKS özet skorları, depresyon ile MKS özet skoru arasında korelasyon saptandı. Sağlıklı kontrollerle karşılaştırıldığında fibromiyalji sendromu yaşam kalitesini olumsuz etkilemektedir. Yorgunluk ve depresyon fibromiyalji sendromlu olgularda sık gözlenen bir semptom olup yaşam kalitesi ile ilişki göstermiştir. Fibromiyaljili olgularda yorgunluk ve depresyonun sağaltılması, yaşam kalitesi düzeyini arttırmada etkili olabilir

Anahtar Kelimeler

• Fibromiyalji,yaşam kalitesi,depresyon,uyku bozukluğu

THE QUALITY OF LIFE LEVEL AND RELATED FACTORS IN FEMALE PATIENTS WITH PRIMARY FIBROMYALGIA SYNDROME

Abstract

To investigate the frequency of sleep disturbance and depression, and the relation between disease related variables and the level of quality of life in female patients with primary fibromyalgia. Forty-nine female patients and 27 healthy women as control group were involved. The pain severity, the presence and the severity of depression, the sleep disturbance and fatigue were evaluated respectively by visual analog scale, Beck Depression Inventory, Pittsburg Sleep Quality Index, and Multidimensional Fatigue Symptom Inventory-Short Form. The level of the quality of life was assessed by using short form 36 SF-36 . 91.8% sleep disturbance, 28.6% mild, 10.2% moderate, 28% severe and 26.5% severe depression and 98% fatigue were identified in our patients. All subgroup scores of SF-36, and mental component score MCS and physical component score PCS summary scores were lower in the FMS patients. There was a correlation between fatigue and PCS and MCS summary scores of SF-36 and between depression and MCS summary scores. FMS does affect the quality of life negatively. The fatigue and depression is common symptoms in patients with fibromyalgia and are related with the level of the quality of life. It may be beneficial to improve fatigue and depression in female patients with fibromyalgia to enhance the level of quality of life

Keywords

• Fibromyalgia,quality of life,depression,sleep disturbance

Kaynakça

1. 1) Akkuş S, Koşar A, Beyazıt O. Fibromiyalji tanısı konan 220 vakanın klinik özellikleri. Türk Fiz Tıp Rehab Derg 1998; 1:41-46.
2. 2) White KP, Speechley M, Harth M. Fibromyalgia in Rheumatology Practice; A survey of Canadian Rheumatologists. J Rheumatol 1995; 22: 722-6.
3. 3) Roizenblatt S, Moldofsky H, BeneditoSilva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001; 44: 222-30.
4. 4) Wolfe F, Smythe H, Yunus M, Bennett RM. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committe. Arthritis Rheum 1990; 33: 160-72.
5. 5) Tüzün EH, Albayrak G, Eker L, Sözay S, Daşkapan A. A comprasion study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil 2004; 26: 198-202.
6. 6)Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF- 36 or the SF-12. J Clin Pract 2008; 62: 115–126.
7. 7) Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571. 8) Hisli N. Beck Depresyon envanterinin geçerliliği üzerine bir çalışma. Türk Psikoloji Dergisi 1989; 22: 118-126.
8. 9) Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.

9. 10) Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 2004; 27: 14-23.
10. 11) Ware JE, Sherbourne CD. The MOS 36-item Short-Form HealthSurvey (SF36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
11. 12) Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33 (4 Suppl): AS264-279.
12. 13) Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healty individuals: utility of shorth form 36 item health survey (SF-36). Pain Res Manag 2009;14: 239-45.
13. 14) Birtane M, Uzunca K, Taştekin N, Tuna H. The evalutation of quality of life in fibromyalgia sydrome: a comparison with rheumatod arhtritis by using SF-36 Health Survey. Clin Rheumatol 2007; 26: 679–684.
14. 15) Bircan Ç, Akkoç Y, Kirazlı Y. Primer fibromiyalji sendromlu hastalarda yaşam kalitesi. Ege Fiz Tıp Reh Der 1999; 5: 241.
15. 16) Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ5D in the DMC3 study. Ann Rheum Dis 2004; 63: 723–729.
16. 17) Stuifbergen AK, Phillips, Voelmeck W, Browder R. Illness perceptions and related outcomes among women with fibromyalgia syndrome. Womens Health Issues 2006;16: 353–360.
17. 18) Marques AP, Ferreira EA, Matsutani LA, Pereira CA, Assumpcao A. Quantifying pain threshold and quality of life of fibromyalgia patients. Clin Rheumatol 2005; 24: 266–271.
18. 19) Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50: 2974-84.
19. 20) Assis MR, Silva LE, Alves AM, Pessanha AP, Valim V, Feldman D, et al. A randomized controlled trial of deep water running: clinical effectiveness of aquatic exercise to treat fibromyalgia. Arthritis Rheum 2006; 55: 57–65.
20. 21) Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebocontrolled study. Am J Med 2003; 114: 537–45.
21. 22) White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 1999; 42: 76-83.
22. 23) Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics 2008; 49: 185–90.
23. 24) Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 2004; 66: 837-44.
24. 25) Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008; 6: 8.
25. 26) Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fibromyalgia. J Psychosom Res 2007; 62: 145– 151.